OSRX Pharmaceuticals

Anthony Sampietro 

President & Chief Executive Officer 

Anthony has more than 17 years of experience developing and running successful ophthalmology medical device and pharmaceutical business units with some of the world’s largest eye care companies (i.e. Alcon, Abbott and J&J) and several successful startups (i.e. Optimedica & LENSAR). Educated at University of Connecticut.

These medications carry serious risks. Please click here to view potential adverse events and contraindications.

*For professional use only. OSRX specializes in customizing compounded medications to meet unique patient and practitioner needs. Compounded drugs are not FDA-approved, which means they have not undergone FDA premarket review for safety, effectiveness, and quality.